Black Titan Corporation (BTTC)
BTTC trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.4380
-10.70% on the day
Market cap
$6.0M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | BTTC on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | Malaysia |
| IPO year | Not reported by the screener |
| SEC CIK | 0002034400 |
| SEC industry code | Services-Computer Programming Services |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-05-18 |
| Latest annual report | 20-F | 2025-11-28 |
| Latest quarterly / interim | 6-K | 2026-10-13 |
Source: SEC EDGAR submissions feed, 80 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CELZ | Creative Medical Technology Holdings Inc. | $0.8199 | -2.51% | $6.2M |
| AIM | AIM ImmunoTech Inc. | $0.1699 | -4.23% | $6.8M |
| LIMN | Liminatus Pharma Inc. | $3.41 | -1.16% | $4.6M |
| SNTI | Senti Biosciences Holdings Inc. | $0.2550 | -19.96% | $7.9M |
| PMCB | PharmaCyte Biotech Inc. | $0.3559 | -2.52% | $3.8M |
| CLDI | Calidi Biotherapeutics Inc. | $0.8999 | -5.26% | $3.3M |
| INTS | Intensity Therapeutics Inc. | $3.55 | +7.25% | $11.6M |
| INAB | IN8bio Inc. | $1.18 | -4.07% | $11.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier